Cancer cells are able to hijack the Keap1-Nrf2 system via multiple mechanisms leading to enhanced chemo- and radioresistance and proliferation via metabolic reprogramming as well as inhibition of apoptosis [241]. The gene discussed is NFE2L2; the disease is cancer.